When stratified by annual rate of eGFR decline, patients with T2DM and DN patients with progressive eGFR decline had significantly higher levels of urinary complement C2, C3, and C9 than those with slow eGFR decline. The gene discussed is C9; the disease is type 2 diabetes mellitus.